What should we do now?
I recognize that this news can be distracting. There has been, and may likely continue to be, intense media speculation surrounding our discussions with Pfizer. I’m committed to providing all employees with information if and when such discussions conclude. In the meantime, I ask that each of you remain focused on delivering on our commitments to our customers and patients who depend upon us. This focus has been our hallmark and has enabled us, collectively as a company and as individual employees, to thrive in times of uncertainty.